Metformin is an old drug. In its earliest form, it was an extract from lilacs and was purportedly used in the 1700s to treat ...

Evercore ISI analyst Umer Raffat initiated coverage of Metsera (MTSR) with an Outperform rating. Metsera has a full portfolio of GLP-1 ...

BofA initiated coverage of Metsera (MTSR) with a Buy rating and $38 price target implying over 20% share upside. Metsera is a clinical-stage ...

New research finds older women achieve the best results with weight loss injections – thanks to consistent tracking and ...

Aardvark Therapeutics has followed up filings and speculation with a $94 million initial public offering, putting itself on ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Alongside the amended certificate, Metsera, Inc. also updated its bylaws.

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) ("Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone ...

Are you on a weight loss journey but struggling to shed those extra kilos? You're not alone. Many people often feel lost about what to eat and do to reach their fitness goals, sometimes blindly ...

(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company ...

The rapper was slated to perform in two shows at the Tokyo Dome in May. But, after his shocking Grammy stunt, he might lose a whooping 20 million dollar international concert deal as the ...

For the full year, Peacock lost Comcast $1.8 billion, which was not as big of a loss as it had in 2023, though still nowhere close to profitability. Meanwhile, the media business is bracing for ...